[1] 孟焕新. 牙周病学[M]. 5版. 北京:人民卫生出版社, 2020:137-139. [2] 李妍, 孟琛达, 徐全臣. 药物性牙龈肥大的病因研究及治疗进展[J]. 国际口腔医学杂志, 2020, 47(6):693-698. [3] Morisaki I, Kato K, Loyola-Rodriguez JP, et al. Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats[J]. J Periodontal Res, 1993, 28(6 Pt 1):396-403. [4] Ma S, Liu P, Li Y, et al. Cyclosporine ainhibitsapoptosis of rat gingival epithelium[J]. J Periodontol, 2014, 85(8):1126-1134. [5] Adachi C, Kitamura K, Kato K, et al. Cyclosporin-A induced gingival overgrowth:Strain differences in the rats[J]. Shoni Shikagaku Zasshi, 1991, 29(1):24-31. [6] Kanno CM, Oliveira JA, Ervolino E, et al. Effects of cyclosporin, nifedipine and phenytoin on gingival myofibroblast transdifferentiation in monkeys[J]. J Appl Oral Sci, 2018, 27:e20180135. [7] Hassell TM, Roebuck S, Page RC, et al. Quantitative histopathologic assessment of developing phenytoin-induced gingival overgrowth in the cat[J]. J Clin Periodontol, 1982, 9(5):365-372. [8] Heijl L, Sundin Y. Nitrendipine-induced gingival overgrowth in dogs[J]. J Periodontol, 1989, 60(2):104-112. [9] Ishida H, Kondoh T, Kataoka M, et al. Factors influencing nifedipine-induced gingival overgrowth in rats[J]. JPeriodontol, 1995, 66(5):345-350. [10] Morisaki I, Akiyama YM, Miyawaki YN, et al. Positive correlation between blood cyclosporin A level and severity of gingival overgrowth in rats[J]. J Periodontol, 1997, 68(1):7-11. [11] Shimizu Y, Shinohara H, Nishikawa S, et al. Transglutaminase activity in rat gingival tissue[J]. Jpn Soc Periodontol, 1995,37:128. [12] Nishikawa S, Nagata T, Morisaki I, et al. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model[J]. J Periodontol, 1996, 67(5):463-471. [13] Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. Histopathologic findings[J]. J Periodontol, 1987, 58(9):639-642. [14] Chang JH, Wang LF, Lu SL, et al. NF-κB enhances androgen receptor expression through 5'-UTR binding in gingival cells[J]. JDentRes, 2015, 94(10):1439-1445. [15] Uzel MI,Kantarci A, Hong HH, et al. Connective tissue growth factor in drug-induced gingival overgrowth[J]. J Periodontol, 2001, 72(7):921-931. [16] Anand AJ, Gopalakrishnan S, Karthikeyan R, et al. Immunohistochemical analysis of the role connective tissue growth factor in drug-induced gingival overgrowth in response to phenytoin, cyclosporine, and nifedipine[J]. J Int Soc Prev Community Dent, 2018, 8(1):12-20. [17] 朱婷婷, 李楠楠, 陈志慧,等. 硝苯地平与环孢素A诱导的牙龈增生大鼠模型中血清TGF-β1的表达[J]. 牙体牙髓牙周病学杂志, 2018, 28(12):689-694. [18] Yang F, Lu J, Yu Y, et al. Epithelial to mesenchymal transition in Cyclosporine A-induced rat gingival overgrowth[J]. Arch Oral Biol, 2017, 81:48-55. [19] Tamamori Y, Tamura Y, Yamazaki T, et al. Establishment of rat model of drug-induced gingival overgrowth induced by continuous administration of phenytoin[J]. J Pharmacol Sci, 2005, 98(3):290-297. [20] Assaggaf MA, Kantarci A, Sume SS, et al. Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice[J]. AmJPathol, 2015, 185(6):1588-1599. [21] Zhao XH, Tay FR, Fang YJ, et al. Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo[J]. Arch Oral Biol, 2019, 97:42-51. [22] 谭葆春,闫福华.控制菌斑和炎症在牙龈肥大治疗中的效果评价[J].中华口腔医学杂志,2021,56(6):510-516. [23] Migliozzi DR, Asal NJ. Clinical controversy in transplantation:Tacrolimus versus cyclosporine in statin drug interactions[J]. Ann Pharmacother, 2020, 54(2):171-177. [24] Aícua-Rapún I, André P, Rossetti AO, et al. Therapeutic drug monitoring of newer antiepileptic drugs:A randomized trial for dosage adjustment[J]. Ann Neurol, 2020, 87(1):22-29. [25] 国家卫生计生委合理用药专家委员会, 中国医师协会高血压专业委员会. 高血压合理用药指南(第2版)[J]. 中国医学前沿杂志(电子版), 2017, 9(7):28-126. [26] Fu E, Nieh S, Hsiao CT, et al. Nifedipine-induced gingival overgrowth in rats:Brief review and experimental study[J]. J Periodontol, 1998, 69(7):765-771. [27] Okanobu A, Matsuda S, Kajiya M, et al. A novel gingival overgrowth mouse model induced by the combination of CsA and ligature-induced inflammation[J]. J Immunol Methods, 2017, 445:31-36. [28] Matsuda S, Okanobu A, Hatano S, et al. Relationship between periodontal inflammation and calcium channel blockers induced gingival overgrowth-a cross-sectional study in a Japanese population[J]. Clin Oral Investig, 2019, 23(11):4099-4105. [29] Li WL, Wu CH, Yang J, et al. Local inflammation alters MMP-2 and MMP-9 gelatinase expression associated with the severity of nifedipine-induced gingival overgrowth:Arat model study[J]. Inflammation, 2015, 38(4):1517-1528. [30] Fernandes MI, Gaio EJ, Susin C, et al. Effect of nifedipine on gingival enlargement and periodontal breakdown in ligature-induced periodontitis in rats[J]. Arch Oral Biol, 2010, 55(7):523-529. [31] Pamuk F, Cetinkaya BO, Gulbahar MY, et al. Effects of tacrolimus and nifedipine, alone or in combination, on gingival tissues[J]. J Periodontol, 2013, 84(11):1673-1682. [32] Greenberg KV, Armitage GC, Shiboski CH. Gingival enlargement among renal transplant recipients in the era of new-generation immunosuppressants[J]. J Periodontol, 2008, 79(3):453-460. [33] Fardal Ø, Lygre H. Management of periodontal disease in patients using calcium channel blockers-gingival overgrowth, prescribed medications, treatment responses and added treatment costs[J]. J Clin Periodontol, 2015, 42(7):640-646. [34] Ma S, Liu W, Liu P, et al.Tanshinone IIA treatment alleviated the rat gingival connective tissue overgrowth induced by cyclosporine A[J]. J Periodontal Res, 2016, 51(5):567-576. [35] Ju YQ, Huang LJ, Wang SW, et al. Transcriptional analysis reveals key genes in the pathogenesis of nifedipine-induced gingival overgrowth[J]. Anal Cell Pathol Amsterdam, 2020, 2020:6128341. [36] Staudinger LA, Spano SJ, Lee WS, et al. Role of discoidin domain receptor 1 in dysregulation of collagen remodeling by cyclosporin A[J]. Int J Biochem Cell Biol, 2015, 62:80-87. [37] Alshargabi R, Sano T, Yamashita A, et al. SPOCK1 is a novel inducer of epithelial to mesenchymal transition in drug-induced gingival overgrowth[J]. Sci Rep, 2020, 10:9785. [38] Yang Y, Huang X, Shi Y, et al. CYP3A5 genotype-dependent drug-drug interaction between tacrolimus and nifedipine in Chinese renal transplant patients[J]. Front Pharmacol, 2021, 12:692922. [39] Hatano S, Matsuda S, Okanobu A, et al. The role of nuclear receptor 4A1 (NR4A1) in drug-induced gingival overgrowth[J]. FasebJ, 2021, 35(7):e21693. [40] 段胜仲. 牙周微生态与心脑血管疾病研究进展[J]. 口腔医学, 2021, 41(7):577-582. |